APA (7th ed.) Citation

Remke, M., Hering, E., Gerber, N. U., Kool, M., Sturm, D., Rickert, C. H., . . . Frühwald, M. C. (2013). Somatostatin receptor subtype 2 (sst2) is a potential prognostic marker and a therapeutic target in medulloblastoma. Child's nervous system, 29(8), . https://doi.org/10.1007/s00381-013-2142-4

Chicago Style (17th ed.) Citation

Remke, Marc, et al. "Somatostatin Receptor Subtype 2 (sst2) Is a Potential Prognostic Marker and a Therapeutic Target in Medulloblastoma." Child's Nervous System 29, no. 8 (2013). https://doi.org/10.1007/s00381-013-2142-4.

MLA (9th ed.) Citation

Remke, Marc, et al. "Somatostatin Receptor Subtype 2 (sst2) Is a Potential Prognostic Marker and a Therapeutic Target in Medulloblastoma." Child's Nervous System, vol. 29, no. 8, 2013, https://doi.org/10.1007/s00381-013-2142-4.